Phospho-Smad2 (Ser250) Polyclonal Antibody, Biotin Conjugated
Product Specifications
Background
Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma.
Synonyms
Smad2 (phospho S250) ; p-Smad2 (phospho S250) ; hMAD 2; hMAD 3; hSMAD2; hSMAD3; Mad related protein 2; MADH2; MADH3; MADR2; Mothers against DPP homolog 2; Mothers against DPP homolog 3; Sma and Mad related protein 2; SMA and MAD related protein 3; SMAD 2; SMAD 3; SMAD family member 2; SMAD family member 3.
Gene ID
4087
Swiss Prot
Q15796
Modification Site
Ser250
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse
Target
Phospho-Smad2 (Ser250)
Clonality
Polyclonal
Isotype
IgG
Conjugation
Biotin
Source
KLH conjugated synthesised phosphopeptide derived from human Smad2 around the phosphorylation site of Ser250
Applications
WB, ELISA
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
WB (1:300-5000), ELISA (1:500-1000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Phosphorylation
Storage Conditions
Store at -20°C for 12 months.
Gene ID URL
4087
Predicted Cross Reactivity
Rat, Dog, Cow, Pig
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15333666 1 Vial
Lentiviral human SEZ6 shRNA (UAS) - Lentiviral human SEZ6 shRNA (UAS, iRFP) (100)
Ask
View Details 
